In a 70-year-old woman with less than 50% atherosclerotic plaque on computed tomography angiography, should she be started on aspirin and a statin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Statin Therapy: Yes. Aspirin: No.

In this 70-year-old woman with <50% coronary plaque on CT angiography, you should initiate statin therapy but NOT aspirin for primary prevention. The presence of any atherosclerotic plaque—even non-obstructive—warrants aggressive lipid management, while aspirin lacks net benefit in primary prevention and carries bleeding risk in this age group.

Statin Recommendation

Start a moderate-to-high intensity statin immediately based on the detection of coronary atherosclerosis 1, 2. The 2019 ACC/AHA guidelines explicitly state that statin therapy is first-line treatment for primary prevention in patients determined to be at sufficient ASCVD risk after clinician-patient discussion 1. At age 70 with documented plaque, she clearly meets this threshold.

Supporting Evidence for Statins

  • Age-specific data strongly supports statin use in this age group. Meta-analyses demonstrate that in patients 65-70 years old, statins reduce composite cardiovascular endpoints by 49%, and even in those ≥70 years, risk reduction remains substantial at 26% 2

  • Non-obstructive plaque matters. Multiple studies show that patients with non-obstructive CAD (<50% stenosis) who receive statins demonstrate:

    • 6-fold increased likelihood of statin initiation/intensification compared to those without plaque 3
    • Significant reductions in LDL cholesterol (-14.1 mg/dL) and total cholesterol (-14.7 mg/dL) 3
    • Improved cardiovascular outcomes when treated 4, 5
  • The plaque itself changes risk stratification. Even <50% stenosis represents established atherosclerotic disease, not just risk factors. This moves the patient from primary prevention based on risk scores to treatment of documented disease 6, 5

Practical Statin Approach

Start with atorvastatin 20-40 mg or rosuvastatin 10-20 mg daily. Target LDL cholesterol <70 mg/dL given documented atherosclerosis. Recheck lipids in 4-6 weeks and titrate accordingly.

Aspirin Recommendation

Do NOT start aspirin in this patient 1. This is a critical point where guidelines have evolved significantly.

Why No Aspirin

  • The 2019 ACC/AHA guidelines explicitly state: "Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit" 1. This is a Class III recommendation (harm may exceed benefit)

  • Age increases bleeding risk substantially. The FDA label warns that bleeding risk is higher in patients ≥60 years old 7. At age 70, this patient faces significant bleeding risk that likely outweighs any cardiovascular benefit

  • Recent high-quality evidence shows no benefit in asymptomatic patients with coronary stenosis. A 2025 propensity-matched study of 636 individuals with incidentally diagnosed coronary stenosis found:

    • No reduction in composite cardiovascular events with aspirin (HR 0.62, P=0.20—not statistically significant) 8
    • Higher bleeding risk in the aspirin group 8
    • No difference in Kaplan-Meier curves for events with or without bleeding 8

Exception to Consider

The only scenario where aspirin might be considered is if she has additional high-risk features such as:

  • Lipoprotein(a) >50 mg/dL (some evidence suggests ~50% risk reduction with aspirin in this specific subgroup) 9
  • Multiple high-risk plaque features on CCTA (low-attenuation plaque, positive remodeling, spotty calcification)
  • Very low bleeding risk (no history of GI bleeding, not on anticoagulation, no significant fall risk)

Even then, this requires careful shared decision-making weighing her specific bleeding versus thrombotic risk.

Risk Factor Management Beyond Medications

While initiating the statin, ensure comprehensive risk factor control:

  • Blood pressure target <130/80 mmHg 1
  • Lifestyle modifications: Mediterranean diet, 150 minutes/week moderate exercise 1
  • Smoking cessation if applicable 1
  • Diabetes management if present, with consideration of SGLT2 inhibitor or GLP-1 agonist for additional cardiovascular benefit 1

Common Pitfalls to Avoid

  1. Don't dismiss non-obstructive plaque as insignificant. <50% stenosis still represents atherosclerotic disease requiring treatment 3, 6

  2. Don't reflexively start aspirin because plaque is present. The bleeding risk in elderly patients outweighs benefit in primary prevention 1, 8

  3. Don't use outdated risk calculators alone. The CT angiography finding supersedes risk score calculations—she has documented disease 6

  4. Don't undertreate lipids. Target LDL <70 mg/dL given atherosclerosis presence, not the more lenient primary prevention targets 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.